Skip to content

Prehabilitation in Breast cancer

Effectiveness of prehabilitation and Lymphedema education on clinical and Functional outcomes among Non-metastatic Breast cancer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098842
Enrollment
30
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Prehabilitation group: Prehabilitation group will receive prehabilitation 1 2 weeks prior to surgery by direct 1:1 education for about 30-45 minutes and participants are instructed to

Sponsors

Kavitha V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects aged between 25 and 60 years who comprehend to commands 2) Subjects who planned for Modified radical mastectomy, Simple mastectomy and Breast conserving surgery with Axillary lymphnode dissection.

Exclusion criteria

Exclusion criteria: 1) Subjects with Metastatic breast cancer 2) Subjects who planned for Lumpectomy, Wide local excision, Flap reconstruction 3) Subjects undergoing Neoadjuvant Radiation therapy 4) Subjects with comorbidities of cardiopulmonary, neurological and musculoskeletal conditions.

Design outcomes

Primary

MeasureTime frame
Shoulder ROM, Grip Strength, SPADI questionnaireTimepoint: Baseline, POD 1, Post drain removal, Post 1 month and Post 2 months of surgery

Secondary

MeasureTime frame
Arm Circumference, Lymphedema Knowledge SurveyTimepoint: Baseline (1-2days prior to surgery), POD 1, Post drain removal, Post 1 month and Post 2 month

Countries

India

Contacts

Public ContactKavitha V

Sri Ramachandra Faculty of Physiotherapy, SRIHER

ramalakshmi22@sriramachandra.edu.in7708680087

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026